Professional Documents
Culture Documents
Introduction To Cns Pharmacology
Introduction To Cns Pharmacology
Drugs affecting the CNS may act presynaptically by influencing the production, storage, or termination of neurotransmitters. Other agents may activate or block postsynaptic receptors.
An overview of the CNS with a focus on Most drugs that affect the central nervous system (CNS) act by altering some step in the neurotransmitters mediating the physiological and pathological responses is essential for understanding neuropharmacology.
G-protein coupled receptors (Metabotropic) NTAs also bind to G protein-coupled receptors Direct opening voltage-channel through SM
CNS PHARMACOLOGY
TYPES OF RECEPTOR-CHANNEL COUPLING 1. Through a receptor that acts directly on the channel protein 2. Through a receptor that is coupled to the ion channel or change ion channel function through a G protein system.
CNS PHARMACOLOGY
ROLE OF THE ION CURRENT CARRIED BY THE CHANNEL SYNAPSE- communication
1. EXCITATORY POSTSYNAPTIC POTENTIALS 2. INHIBITORY POSTSYNAPTIC POTENTIALS
CNS PHARMACOLOGY
EXCITATORY POSTSYNAPTIC POTENTIALS (EPSPs) Depolarizing potential change Generated by Opening of sodium or calcium channels Closing of potassium channels
CNS PHARMACOLOGY
EXCITATORY POSTSYNAPTIC POTENTIALS (EPSPs) Na+, K+, Ca+2
-70 mV
CNS PHARMACOLOGY
INHIBITORY POSTSYNAPTIC POTENTIALS (IPSPs) Hyperpolarizing potential change Generated by Opening of potassium or chloride channels
CNS PHARMACOLOGY
INHIBITORY POSTSYNAPTIC POTENTIALS (IPSPs) K+ , Cl- at the postsynaptic , Ca+2 at the presynaptic
-70 mV
CNS PHARMACOLOGY
SITES AND MECHANISMS OF DRUG ACTION Some drugs exert their effect through direct interactions with molecular components of ion channels on axons Carbamazepine Phenytoin Local anesthetics and some drugs used for general anesthesia
CNS PHARMACOLOGY
SITES AND MECHANISMS OF DRUG ACTION
CNS PHARMACOLOGY
SITES AND MECHANISMS OF DRUG ACTION
May alter Neurotransmitter Synthesis Storage Release Reuptake Metabolism
CNS PHARMACOLOGY
SITES AND MECHANISMS OF DRUG ACTION Activate or block Pre- and postsynaptic receptors for specific transmitters
CNS PHARMACOLOGY
CNS ORGANIZATION
Major excitatory transmitters Aspartate Glutamate
CNS PHARMACOLOGY
CNS ORGANIZATION 2 TYPES OF NEURONAL SYSTEM Major inhibitory transmitters: Gamma amino butyric acid (GABA) Glycine
Pharmacological
MAO inhibitors, SSRI,
Clinical use
Antidepressants, Antipsychotic agents
Classification
sedatives hypnotics drugs Drugs that reduce anxiety and cause sleep Examples Barbiturates, benzodiazepines
Classification
2. Antipsychotic drugs (neuroleptics, anti-schizophrenia Drugs that are effective in relieving symptoms of schizophrenic illness Examples Clozapine, Haloperidol
Classification
3. Antidepressant drugs Drugs that alleviate the symptoms of depressive illness Examples TCA, MAOI, SSRI
Classification
4. Psychomotor stimulants (Psychostimulants) Drugs that can cause wakefulness and euphoria Examples Amphetamines, Cocaine, and caffeine
5. Anticonvulsants: Drugs that prevent or suppress convulsions. 6.Analgesics: Drugs that relieve pain without causing loss of consciousness. 7. General anesthetics: Drugs that produce reversible depression of the CNS leading to loss of consciousness and loss of sensations surgical operations.
Sedative Hypnotics
Anxiety disorders Is unpleasant state of tension, apprehension or uneasiness . A fear that seems to arise from a sometimes unknown source . Most common mental disturbance.
Anxiety is a universal human characteristic which serves as adaptive mechanism to warn about an external threat by activating the sympathetic NS. Anxiety is in many cases secondary to organic disease (e.g MI,angina, peptic ulcers) which themselves require specific therapy. Or due to Drug-Induced. or Drug Withdrawal
Manifestations of anxiety:
Verbal complaints. The patient says he/she is anxious, nervous. Somatic and autonomic effects. The patient is restless and agitated, has tachycardia, increased sweating, breathlessness, tremor, fatigue, disturbed sleep. . Social effects. Interference with normal productive activities.
www.freelivedoctor.com
Anxiety become pathological when: 1.Fear is greatly out-of-proportion to risk/ severity of threat. 2.Response continues beyond existence of threat. 3.Social or occupational functioning is impaired.
SLEEP
33
During sleep, the brain generates a patterned rhythmic activity that can be monitored bymeans of the electroencephalogram (EEG). Internal sleep cycles recur 45 times per night
Normal sleep
Normal sleep cyclic and repetitive, consists of distinct stages: Non-rapid eye movement(NREM) sleep: 70%-75% Stage 1,2 Stage 3,4:slow wave sleep, SWS Most sleep stage 2. Rapid eye movement(REM) sleep Recalled dreams. Both NREM & REM occur cyclically over an interval of about 90 min.
rapid eye movement (REM) sleep phase The REMstage is characterized by EEG activity similar to that seen in the waking state, rapid eye movements, vivid dreams, and occasional REM stage is entered only after a preceding non-REM cycle.
insomnia is "difficulty initiating or maintaining sleep, or both" or the perception of poor quality sleep.
General anesthetic: the drug which causes reversible and controllable loss of consciousness associated with absence of response to pain. Sedation Hypnosis Anesthesia Coma and death. After progressive dose increments.
CHEMICAL CLASSIFICATION
1. Benzodiazepines: not to lead general anesthesia, raraly death. 2. Barbiturates: the older sedative-hypnotics, general depression of central nervous system. With such drugs, an increase in dose above that needed for hypnosis may lead to a state of general anesthesia. At still higher doses, it may depress respiratory and vasomotor centers in the medulla, leading to coma and death.
DRUG A - BARBITURATES dose = CNS depression DRUG B - BENZODIAZEPINES - flatter dose response curve - greater margin of safety
SEDATIVE/HYPNOTICS ANXYOLITICS
BENZODIAZEPINES BARBITURATES
GABAergic SYSTEM
www.freelivedoctor.com
.Benzodiazepines
Classification Short acting e.g. Midazolam Intermediate acting e.g. Alprazolam Long acting e.g. Diazepam
The BNZ for most part, end in pam or lam
MOA:
MOA: GABA (-amino butyric acid) is an inhibitory neurotransmitter Binding of GABA to its receptor on cell membrane trigger an opening of Clchannel Influx of Cl- leads to hyperpolarization
BZ binds to specific receptor adjacent to GABA receptor This binding potentiate binding of GABA on its receptor
Pharmacokinetics
Most of these drugs are lipid-soluble & are absorbed from GIT Good distribution to the brain Metabolism: most BZ metabolized by hepatic Cyt-P450 to compounds that are also active
Benzodiazepines with intermediate or long durations of action are favored Alprazolam for Phobic and panic attacks
Adverse effects
Day time drowsiness Cognitive impairment Blurred vision & confusion Tolerence and dependence (physical and psycological). Specially in high dose for long period. Withdrawal manifestation are more with BDZ of short duration.
Long-term Effects
Tolerance develops, resulting in dependence
Must have more and more of the drug to feel an even minor effects Higher risk of overdose
Withdrawal
This leads to dependence as well No one wants to feel the unpleasant withdrawal effects, so continues use (2)
57
58
BZs antagonists Flumazenil reverse the effects of BZs This drug is available by I.V. administration only Has rapid onset
.BARBITURATES They were formerly used to sedate the patient; today they have been replaced by BZ because:
1. 2. 3. 4. BZ are safer (wide therapeutic index) BZ have risk of physical dependence BZ have drug-drug interaction (less induction of liver enzymes) BZs have less withdrawal symptoms
.BARBITURATES
Classification
(1)Ultra-short-acting barbiturates: act within seconds, and their duration of action is 30min. Therapeutic use of Thiopental is used I.V. to induce anesthesia (2)Long-acting barbiturates: have a duration of action greater than 6h. Such as Phenobarbital. Therapeutic uses: hypnotics and sedative, and antiepileptic agents for long term management of Tonic-Clonic seizure & status epilepticus
MECHANISM OF ACTION
Barbiturates share with benzodiazepines the ability to enhance the action of GABA, but they bind a different site on the GABAreceptor/chloride channel, and their action seems to prolong the duration of the opening of GABA-activated chloride channels.
S/Es CNS: Drowsiness, impaired concentration Respiratory depression: in dose that may lead to death
BZ
Barb.
High Low
Low High
Low High
Suicide Potential
Abuse Potential Antagonist Available?
Low High
Low High Yes No
Other agents E.g.: Buspirone MOA: It is mediated by serotonin (5-HT1A) receptors Uses: Treatment of generalized anxiety disorders Lack anticonvulsant & muscle relaxant properties
Other anxiolytic agent: Hydroxyzine: an antihistamine that is useful for patients with anxiety disorders who have history of drug abuse. often used for sedation prior dental procedure or surgery. Drowsiness is possible adverse effects